Podiatrist · Cleveland, OH
NPI
1295835510
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
847 services
Medicare patients, 2024
524
Average age 74
Drug cost, 2024
$49K
704 prescriptions
Company payments, 2024
$18.65
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dina Stock was code 99213 (office e&m - established), 352 times for 267 patients. In total Dina Stock billed 847 services in 26 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 352 | 267 | $44.59 | $16K |
| 99203 Office E&M - New | Office | 257 | 257 | $51.97 | $13K |
| 11721 Nail Procedure | Office | 54 | 28 | $15.99 | $863 |
| 11720 Nail Procedure | Office | 42 | 36 | $10.02 | $421 |
| 97597 Debridement | Office | 36 | 14 | $26.89 | $968 |
| G0247 Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following i | Office | 15 | 11 | $15.33 | $230 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.49 | $175 |
| 99212 Office E&M - Established | Office | 14 | 13 | $24.84 | $348 |
By year: 2022 $34K for 781 services; 2023 $33K for 799 services; 2024 $35K for 847 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dina Stock prescribed most often to Medicare patients was Econazole Nitrate, with 275 prescriptions and refills. In total Dina Stock wrote 704 Medicare prescriptions that cost $49K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Econazole Nitrate Generic | 275 | 349 | 134 | $7,519 |
| Clotrimazole Generic | 114 | 143 | 49 | $1,733 |
| Ammonium Lactate Generic | 103 | 135 | 54 | $2,530 |
| Ciclopirox Generic | 74 | 82 | 28 | $1,815 |
| Cephalexin Generic | 28 | 28 | 27 | $252 |
| Terbinafine Hcl Generic | 23 | 23 | Under 11 | $234 |
| Doxycycline Hyclate Generic | 21 | 21 | 19 | $215 |
| Jublia Efinaconazole | 20 | 26 | Under 11 | $31K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 17 | 17 | 16 | $305 |
Brand drugs: 29 claims; generic drugs: 675 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Dina Stock $18.65 ($18.65 in general payments such as food, travel and fees) from 1 company. The largest payer was Smith+Nephew, Inc. with $18.65.
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. SNN | 1 | $18.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.